WHO vaccine-preventable diseases: monitoring system. 2015 global summary

Last updated 15-Jul-2015 (Data received as of 10-Jul-2015)
Next overall update Fall 2015
EPI mother and child logo         
Select a country

Development status: Least developed GNI / capita (US$): 2701 Infant (under 12 months) mortality rate: 672
GDP / capita (US$): 7941 Child (under 5 years) mortality rate: 1042

Population data in thousands3

  2014  2013  2012  2011  2010  2000  1990  1980 
Total population 10'483  10'163  9'850  9'540  9'233  6'674  5'606  4'127 
Births 465  455  443  431  417  288  277  210 
Surviving infants 426  416  405  393  380  258  245  185 
Pop. less than 5 years 1'950  1'897  1'838  1'769  1'685  1'197  1'135  782 
Pop. less than 15 years 4'691  4'529  4'370  4'213  4'056  3'269  2'682  1'831 
Female 15-49 years 2'487  2'419  2'353  2'287  2'221  1'447  1'234  974 

Number of reported case

(Click for retrospective incidence data for Burundi)
Diphtheria
Japanese encephalitis
Measles 49  129  495  18'363  13'282  49'227 
Mumps
Pertussis 72  529  9'613 
Polio* 10  43 
Rubella 71  11  67  247 
Rubella (CRS)
Tetanus (neonatal) 16  25 
Tetanus (total)** 33  65  256 
Yellow fever
* Polio refers to all polio cases (indigenous or imported), including polio cases caused by vaccine derived polio viruses (VDPV). For desagregated data please click on this hyperlink: https://extranet.who.int/polis/public/CaseCount.aspx
it does not include cases of vaccine-associated paralytic polio (VAPP) and cases of non polio acute flaccid paralysis [AFP]).
** Neonatal Tetanus and Total Tetanus cases equality may be the result from a lack of non-Neonatal Tetanus surveillance system.

Percentage target population vaccinated by antigen

Hovering over an antigen reveals its fuller definition
  Most recent coverage survey4  

Official country estimates5

  (Click for retrospective coverage estimates data for Burundi)
Vaccine year result method % card seen                                                
BCG 2011  98  EPI   51  92  95  98  90  93  73  97 
DTP1 2011  99  EPI   51  98  98  98  99*  99  74 
DTP3 2011  98  EPI   51  95  96  96  99*  96  68  86 
DTP4         
IPV1         
HepB_BD         
HepB3 2011  98  EPI   51  95  96  96  99*  96 
Hib3 2011  98  EPI   51  95  96  96  99*  96 
JapEnc         
MCV1          94  98  93  99*  92  61  74 
MCV2          60  51 
PCV1          98  98  99*  31 
PCV3          95  96  99*  14 
Pol3 2011  98  EPI   51  95  96  96  99*  94  69  97 
Rota1          98  14 
Rota_last          96 
Rubella1         
TT2plus 2009  32  DHS   62  80  96  88  99*  94  28  56 
PAB         
VAD1          15  27  27  72 
YFV         
  ° indicates that more than 1 survey occurred that year

  Next update: Mid July 2016

WHO-UNICEF estimates6

  (Click for full retrospective WHO-UNICEF coverage estimates data for Burundi)
BCG 92  95  98  90  93  85  97 
DTP1 98  98  98  99  99  88  95 
DTP3 95  96  96  96  96  80  86 
HepB3 95  96  96  96  96 
HepB_BD
Hib3 95  96  96  96  96 
MCV1 94  98  93  93  92  72  74 
MCV2 60  51 
PAB 85  85  85  80  94  51  67 
PCV3 95  96  96  14 
Pol3 95  96  96  95  94  71  97 
Rota_last 96 
YFV

Number of districts in the country 45  Proportion of
districts reporting
DTP3 coverage:
% of coverage reports received at national
level vs number of reports expected
100 
   
/
|
|
\
Greater or equal to 90% 67
From 80 to 89% 18
From 50 to 79% 16
Less than 50% 0
Proportion of districts
not reporting DTP3 coverage
0
 

Immunization Schedule (2014 or latest available)

Hovering over an antigen reveals its fuller definition
Vaccine Schedule Entire country Comment
BCG birth; Yes
DTwPHibHepB 6, 10, 14 weeks; Yes
HPV No From January 2016
IPV 14 weeks; Yes From November 2015
Measles 9, 18 months; Yes
OPV birth; 6, 10, 14 weeks; Yes
Pneumo_conj 6, 10, 14 weeks; Yes
Rotavirus 6, 10 weeks; Yes
Td 1st contact; +1,+6 months; +1, +1 year; Yes
VitaminA 9 months; Yes

Immunizaton indicators

Indicator Expected answer 2014  2013  2012  2011  2010  2009  2008 

Planning and management

Has the country a Multi-Year Plan (MYP) for immunization? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 
What years does the MYP cover? number 2011-2015  2011-2015  2011-2015  2011-2015  2010-2014  2010-2014  2006 - 2010 
Nº of districts with microplans that include activities to raise immunization coverage number 45  45  45  45  45  45  12 

System performance

Total Nº districts in country number 45  45  45  45  45  43  41 
Nº districts with DTP3 coverage >=80% number 38  42  42  44  41  39  30 
% of districts with DTP3 coverage >=80% From 0 to 100% 84  93  93  98  91  91  73 
Nº districts with measles (MCV1) coverage >=95% number 20  27  31  29  16  24  11 
% of districts with MCV1 coverage >=95% From 0 to 100% 44  60  69  64  36  56  27 

Safety

Has the country a vaccine adverse events review committee? Yes/No/NR/ND No  No  No  No  No     
Is there a national system to monitor adverse events following immunization (AEFI)? Yes/No/NR No  Yes  Yes  Yes  Yes  Yes  Yes 

Finance

Immunization expenditure financed, using Government funds? From 0 to 100%     10  22   

National Immunization Advisory Mechanism

Has the country a standing technical advisory group on immunization (NITAG)? Yes/No/NR No  No  No  No  No     

Sources

 1  "The 2015 World Bank Development Indicators Online", GDP per capita is PPP adjusted.
 2  World Health Statistics 2013, data for 2012
 3  "United Nations, Population Division. The World Population Prospects - the 2012 revision". New York, 2013.
 4  UNICEF/WHO survey database
 5  If no official estimate is available, the administrative coverage is reported. '*' indicates coverage over 99.5%.
 6  WHO-UNICEF estimates.